These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 11197402)
1. Inhaled nitric oxide in neonates with persistent pulmonary hypertension. Tworetzky W; Bristow J; Moore P; Brook MM; Segal MR; Brasch RC; Hawgood S; Fineman JR Lancet; 2001 Jan; 357(9250):118-20. PubMed ID: 11197402 [TBL] [Abstract][Full Text] [Related]
2. The use of inhaled nitric oxide in newborn medicine. Golombek SG Heart Dis; 2000; 2(5):342-7. PubMed ID: 11728280 [TBL] [Abstract][Full Text] [Related]
3. Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up. Clark RH; Huckaby JL; Kueser TJ; Walker MW; Southgate WM; Perez JA; Roy BJ; Keszler M; J Perinatol; 2003 Jun; 23(4):300-3. PubMed ID: 12774137 [TBL] [Abstract][Full Text] [Related]
4. Outcome of neonates with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide. Chotigeat U; Khorana M; Kanjanapatakul W J Med Assoc Thai; 2002 Jul; 85(7):800-7. PubMed ID: 12296412 [TBL] [Abstract][Full Text] [Related]
5. Inhaled nitric oxide and methemoglobin in full-term infants with persistent pulmonary hypertension of the newborn. Salguero KL; Cummings JJ Pulm Pharmacol Ther; 2002; 15(1):1-5. PubMed ID: 11969358 [TBL] [Abstract][Full Text] [Related]
6. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside. Kieler-Jensen N; Lundin S; Ricksten SE J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728 [TBL] [Abstract][Full Text] [Related]
7. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. Kinsella JP; Neish SR; Ivy DD; Shaffer E; Abman SH J Pediatr; 1993 Jul; 123(1):103-8. PubMed ID: 8320602 [TBL] [Abstract][Full Text] [Related]
8. [The effect of nitric oxide administration on pateints with pulmonary hypertension: a dose-response study]. He J; Cheng X; Xiong C Zhonghua Yi Xue Za Zhi; 1998 Feb; 78(2):105-6. PubMed ID: 10923418 [TBL] [Abstract][Full Text] [Related]
9. Low-dose inhaled nitric oxide in term and near-term infants with hypoxic respiratory failure: a Malaysian experience. Goh AY; Lum LC; Roziah M Med J Malaysia; 2001 Sep; 56(3):336-40. PubMed ID: 11732080 [TBL] [Abstract][Full Text] [Related]
10. Methemoglobin to cumulative nitric oxide ratio and response to inhaled nitric oxide in PPHN. Pabalan MJ; Nayak SP; Ryan RM; Kumar VH; Lakshminrusimha S J Perinatol; 2009 Oct; 29(10):698-701. PubMed ID: 19554014 [TBL] [Abstract][Full Text] [Related]
11. Use of inhaled nitric oxide for the treatment of persistent pulmonary hypertension of the newborn (PPHN). Robinson T; Stewart DL; Hilbert T J Ky Med Assoc; 1999 Mar; 97(3):100-4. PubMed ID: 10189770 [No Abstract] [Full Text] [Related]
12. Inhaled nitric oxide during extracorporeal membrane oxygenation for the treatment of severe persistent pulmonary hypertension of the newborn. Müller W; Kachel W; Lasch P; Varnholt V; König S Artif Organs; 1996 Jan; 20(1):60-3. PubMed ID: 8645132 [TBL] [Abstract][Full Text] [Related]
13. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. Kelly LK; Porta NF; Goodman DM; Carroll CL; Steinhorn RH J Pediatr; 2002 Dec; 141(6):830-2. PubMed ID: 12461501 [TBL] [Abstract][Full Text] [Related]
14. Effect of inhaled nitric oxide on experimentally induced pulmonary hypertension in neonatal foals. Lester GD; DeMarco VG; Norman WM Am J Vet Res; 1999 Oct; 60(10):1207-12. PubMed ID: 10791931 [TBL] [Abstract][Full Text] [Related]
15. Outcome of oral sildenafil therapy on persistent pulmonary hypertension of the newborn at Queen Sirikit National Institute of Child Health. Khorana M; Yookaseam T; Layangool T; Kanjanapattanakul W; Paradeevisut H J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S64-73. PubMed ID: 22043756 [TBL] [Abstract][Full Text] [Related]
16. Inhaled nitric oxide reduction in systolic pulmonary artery pressure is less in patients with decreased left ventricular ejection fraction. Cujec B; Hurst T; McCuaig R; Antecol D; Mayers I; Johnson D Can J Cardiol; 1997 Sep; 13(9):816-24. PubMed ID: 9343030 [TBL] [Abstract][Full Text] [Related]
18. Pharmacology of milrinone in neonates with persistent pulmonary hypertension of the newborn and suboptimal response to inhaled nitric oxide. McNamara PJ; Shivananda SP; Sahni M; Freeman D; Taddio A Pediatr Crit Care Med; 2013 Jan; 14(1):74-84. PubMed ID: 23132395 [TBL] [Abstract][Full Text] [Related]
19. Effects of inhaled nitric oxide in patients with hypoxemia and pulmonary hypertension after cardiac surgery. Bender KA; Alexander JA; Enos JM; Skimming JW Am J Crit Care; 1997 Mar; 6(2):127-31. PubMed ID: 9172849 [TBL] [Abstract][Full Text] [Related]
20. The Use of Inhaled Nitric Oxide in a Tertiary Neonatal Intensive Care Unit. Breatnach CR; Flanagan F; James A; Corcoran JD; Franklin O; El-Khuffash A Ir Med J; 2015 Oct; 108(9):275-8. PubMed ID: 26625652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]